353 related articles for article (PubMed ID: 31186157)
1. Neuropsychiatric Symptoms as Risk Factors for Cognitive Decline in Clinically Normal Older Adults: The Cache County Study.
Burhanullah MH; Tschanz JT; Peters ME; Leoutsakos JM; Matyi J; Lyketsos CG; Nowrangi MA; Rosenberg PB
Am J Geriatr Psychiatry; 2020 Jan; 28(1):64-71. PubMed ID: 31186157
[TBL] [Abstract][Full Text] [Related]
2. Neuropsychiatric symptoms as predictors of conversion from MCI to dementia: a machine learning approach.
Mallo SC; Valladares-Rodriguez S; Facal D; Lojo-Seoane C; Fernández-Iglesias MJ; Pereiro AX
Int Psychogeriatr; 2020 Mar; 32(3):381-392. PubMed ID: 31455461
[TBL] [Abstract][Full Text] [Related]
3. Neuropsychiatric symptoms and the outcome of cognitive trajectories in older adults free of dementia: The Mayo Clinic Study of Aging.
Krell-Roesch J; Syrjanen JA; Machulda MM; Christianson TJ; Kremers WK; Mielke MM; Knopman DS; Petersen RC; Vassilaki M; Geda YE
Int J Geriatr Psychiatry; 2021 Sep; 36(9):1362-1369. PubMed ID: 33724517
[TBL] [Abstract][Full Text] [Related]
4. Persisting neuropsychiatric symptoms, Alzheimer's disease, and cerebrospinal fluid cortisol and dehydroepiandrosterone sulfate.
Ouanes S; Rabl M; Clark C; Kirschbaum C; Popp J
Alzheimers Res Ther; 2022 Dec; 14(1):190. PubMed ID: 36529757
[TBL] [Abstract][Full Text] [Related]
5. Examining the Link Between Cardiovascular Risk Factors and Neuropsychiatric Symptoms in Mild Cognitive Impairment and Major Depressive Disorder in Remission.
Fischer CE; Kortebi I; Karameh WK; Kumar S; Gallagher D; Golas A; Munoz D; Barfett J; Butters MA; Bowie CR; Flint A; Rajji T; Herrmann N; Pollock BG; Mulsant B; Schweizer TA; Mah L;
J Alzheimers Dis; 2019; 67(4):1305-1311. PubMed ID: 30741676
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychiatric Symptoms and Functional Decline in Alzheimer's Disease and Lewy Body Dementia.
Borda MG; Aarsland D; Tovar-Rios DA; Giil LM; Ballard C; Gonzalez MC; Brønnick K; Alves G; Oppedal K; Soennesyn H; Vik-Mo AO
J Am Geriatr Soc; 2020 Oct; 68(10):2257-2263. PubMed ID: 32738062
[TBL] [Abstract][Full Text] [Related]
7. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease, and its relationship with cognitive impairment.
M FM; Molano A; Castro J; Zarranz JJ
Curr Alzheimer Res; 2010 Sep; 7(6):517-26. PubMed ID: 20455862
[TBL] [Abstract][Full Text] [Related]
9. Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer's disease.
Siafarikas N; Selbaek G; Fladby T; Šaltytė Benth J; Auning E; Aarsland D
Int Psychogeriatr; 2018 Jan; 30(1):103-113. PubMed ID: 28927477
[TBL] [Abstract][Full Text] [Related]
10. Malnutrition and neuropsychiatric symptoms in dementia: the Cache County Dementia Progression Study.
Kauzor K; Drewel M; Gonzalez H; Rattinger GB; Hammond AG; Wengreen H; Lyketsos CG; Tschanz JT
Int Psychogeriatr; 2023 Nov; 35(11):653-663. PubMed ID: 37246509
[TBL] [Abstract][Full Text] [Related]
11. Association of brain amyloidosis with the incidence and frequency of neuropsychiatric symptoms in ADNI: a multisite observational cohort study.
Goukasian N; Hwang KS; Romero T; Grotts J; Do TM; Groh JR; Bateman DR; Apostolova LG
BMJ Open; 2019 Dec; 9(12):e031947. PubMed ID: 31857304
[TBL] [Abstract][Full Text] [Related]
12. Course of neuropsychiatric symptoms in dementia: 5-year longitudinal study.
Vik-Mo AO; Giil LM; Ballard C; Aarsland D
Int J Geriatr Psychiatry; 2018 Oct; 33(10):1361-1369. PubMed ID: 29979473
[TBL] [Abstract][Full Text] [Related]
13. Neuropsychiatric symptoms in severe dementia: Associations with specific cognitive domains the Cache County Dementia Progression Study.
Rozum WJ; Cooley B; Vernon E; Matyi J; Tschanz JT
Int J Geriatr Psychiatry; 2019 Jul; 34(7):1087-1094. PubMed ID: 30945374
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of mild behavioral impairment in mild cognitive impairment and subjective cognitive decline, and its association with caregiver burden.
Sheikh F; Ismail Z; Mortby ME; Barber P; Cieslak A; Fischer K; Granger R; Hogan DB; Mackie A; Maxwell CJ; Menon B; Mueller P; Patry D; Pearson D; Quickfall J; Sajobi T; Tse E; Wang M; Smith EE;
Int Psychogeriatr; 2018 Feb; 30(2):233-244. PubMed ID: 28879833
[TBL] [Abstract][Full Text] [Related]
15. Neuropsychiatric symptoms in older people with and without cognitive impairment.
Brodaty H; Heffernan M; Draper B; Reppermund S; Kochan NA; Slavin MJ; Trollor JN; Sachdev PS
J Alzheimers Dis; 2012; 31(2):411-20. PubMed ID: 22571979
[TBL] [Abstract][Full Text] [Related]
16. Neuropsychiatric and Cognitive Symptoms Across the Alzheimer Disease Clinical Spectrum: Cross-sectional and Longitudinal Associations.
Eikelboom WS; van den Berg E; Singleton EH; Baart SJ; Coesmans M; Leeuwis AE; Teunissen CE; van Berckel BNM; Pijnenburg YAL; Scheltens P; van der Flier WM; Ossenkoppele R; Papma JM
Neurology; 2021 Sep; 97(13):e1276-e1287. PubMed ID: 34413181
[TBL] [Abstract][Full Text] [Related]
17. Neuropsychiatric Symptoms and Risk Factors in Mild Cognitive Impairment: A Cohort Investigation of Elderly Patients.
Yang AN; Wang XL; Rui HR; Luo H; Pang M; Dou XM
J Nutr Health Aging; 2020; 24(2):237-241. PubMed ID: 32003417
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer's disease with dementia.
Siafarikas N; Alnæs D; Monereo-Sanchez J; Lund MJ; Selbaek G; Stylianou-Korsnes M; Persson K; Barca ML; Almdahl IS; Fladby T; Aarsland D; Andreassen OA; Westlye LT
Int Psychogeriatr; 2021 Nov; 33(11):1217-1228. PubMed ID: 34399870
[TBL] [Abstract][Full Text] [Related]
19. Plasma Phosphorylated Tau at Threonine 181 and Neuropsychiatric Symptoms in Preclinical and Prodromal Alzheimer Disease.
Ghahremani M; Wang M; Chen HY; Zetterberg H; Smith E; Ismail Z;
Neurology; 2023 Feb; 100(7):e683-e693. PubMed ID: 36323521
[TBL] [Abstract][Full Text] [Related]
20. Vascular risk factors and neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study.
Steinberg M; Hess K; Corcoran C; Mielke MM; Norton M; Breitner J; Green R; Leoutsakos J; Welsh-Bohmer K; Lyketsos C; Tschanz J
Int J Geriatr Psychiatry; 2014 Feb; 29(2):153-9. PubMed ID: 23681754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
